Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia

British Journal of Haematology

Volumn 165, Issue 5, 2014, Pages 688-698

  Lang, Peter ^a   Teltschik, Heiko Manuel ^a   Feuchtinger, Tobias ^a   Müller, Ingo ^a   Pfeiffer, Matthias ^a   Schumm, Michael ^a   Ebinger, Martin ^a   Schwarze, Carl P ^a   Gruhn, Bernd ^b   Schrauder, Andre ^c   Albert, Michael H ^d   Greil, Johann ^e   Urban, Christian ^f   Handgretinger, Rupert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

B cell depletion; Children; Haploidentical; Stem cell transplantation; T cell depletion

Indexed keywords

CLOFARABINE; FLUDARABINE; MELPHALAN; THIOTEPA; CD19 ANTIGEN; CD3 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CANCER SURVIVAL; CARDIOMYOPATHY; CARDIOTOXICITY; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DIARRHEA; DRUG SAFETY; EVENT FREE SURVIVAL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HUMAN; HYPERBILIRUBINEMIA; HYPERTRANSAMINASEMIA; INFECTION; LEUKEMIA RELAPSE; LEUKOENCEPHALOPATHY; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; LUNG TOXICITY; LYMPHOCYTE COUNT; MORTALITY; MULTICENTER STUDY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NAUSEA; NEUROLOGIC DISEASE; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RETRANSPLANTATION; SEIZURE; STEM CELL MOBILIZATION; STOMATITIS; T CELL DEPLETION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; BLOOD; CLINICAL TRIAL; FEASIBILITY STUDY; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE DEPLETION; MALE; MYELODYSPLASTIC SYNDROMES; OPPORTUNISTIC INFECTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY; RECURRENT DISEASE; SURVIVAL; YOUNG ADULT;

ADOLESCENT; ANTIGENS, CD19; ANTIGENS, CD3; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE DEPLETION; MALE; MYELODYSPLASTIC SYNDROMES; OPPORTUNISTIC INFECTIONS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900490083     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12810     Document Type: Article

References (38)

1. Aversa, F., Terenzi, A., Tabilio, A., Falzetti, F., Carotti, A., Ballanti, S., Felicini, R., Falcinelli, F., Velardi, A., Ruggeri, L., Aloisi, T., Saab, J.P., Santucci, A., Perruccio, K., Martelli, M.P., Mecucci, C., Reisner, Y. & Martelli, M.F. (2005) Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. Journal of Clinical Oncology, 23, 3447-3454.
2. Aversa, F., Reisner, Y. & Martelli, M.F. (2008) The haploidentical option for high-risk haematological malignancies. Blood Cells, Molecules, & Diseases, 40, 8-12.
3. Bader, P., Holle, W., Klingebiel, T., Handgretinger, R., Niethammer, D. & Beck, J. (1996) Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT. Anticancer Research, 16, 1759-1763.
4. Beck, J.C., Wagner, J.E., DeFor, T.E., Brunstein, C.G., Schleiss, M.R., Young, J.A., Weisdorf, D.H., Cooley, S., Miller, J.S. & Verneris, M.R. (2010) Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol Blood Marrow Transplant, 16, 215-222.
5. Cerwenka, A. & Lanier, L.L. (2001) Natural killer cells, viruses and cancer. Nature Reviews Immunology, 1, 41-49.
6. Chen, X., Hale, G.A., Barfield, R., Benaim, E., Leung, W.H., Knowles, J., Horwitz, E.M., Woodard, P., Kasow, K., Yusuf, U., Behm, F.G., Hayden, R.T., Shurtleff, S.A., Turner, V., Srivastava, D.K. & Handgretinger, R. (2006) Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. British Journal of Haematology, 135, 524-532.
7. Ciceri, F., Labopin, M., Aversa, F., Rowe, J.M., Bunjes, D., Lewalle, P., Nagler, A., Di Bartolomeo, P., Lacerda, J.F., Lupo Stanghellini, M.T., Polge, E., Frassoni, F., Martelli, M.F. & Rocha, V. (2008) A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. Blood, 112, 3574-3581.
8. Eapen, M., Rubinstein, P., Zhang, M.J., Stevens, C., Kurtzberg, J., Scaradavou, A., Loberiza, F.R., Champlin, R.E., Klein, J.P., Horowitz, M.M. & Wagner, J.E. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet, 369, 1947-1954.
9. Feuchtinger, T., Lang, P., Hamprecht, K., Schumm, M., Greil, J., Jahn, G., Niethammer, D. & Einsele, H. (2004) Isolation and expansion of human adenovirus-specific CD4 + and CD8 + T cells according to IFN-gamma secretion for adjuvant immunotherapy. Experimental Hematology, 32, 282-289.
10. Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F.R., Beck, R., Schumm, M., Lotfi, R., Jahn, G. & Lang, P. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 134, 64-76.
11. Geyer, M.B., Jacobson, J.S., Freedman, J., George, D., Moore, V., van de Ven, C., Satwani, P., Bhatia, M., Garvin, J.H., Bradley, M.B., Harrison, L., Morris, E., Della-Latta, P., Schwartz, J., Baxter-Lowe, L.A. & Cairo, M.S. (2011) A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. British Journal of Haematology, 155, 218-234.
12. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295-304.
13. Handgretinger, R., Klingebiel, T., Lang, P., Schumm, M., Neu, S., Geiselhart, A., Bader, P., Schlegel, P.G., Greil, J., Stachel, D., Herzog, R.J. & Niethammer, D. (2001) Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplantation, 27, 777-783.
14. Jeha, S., Gaynon, P.S., Razzouk, B.I., Franklin, J., Kadota, R., Shen, V., Luchtman-Jones, L., Rytting, M., Bomgaars, L.R., Rheingold, S., Ritchey, K., Albano, E., Arceci, R.J., Goldman, S., Griffin, T., Altman, A., Gordon, B., Steinherz, L., Weitman, S. & Steinherz, P. (2006) Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Journal of Clinical Oncology, 24, 1917-1923.
15. Jeha, S., Razzouk, B., Rytting, M., Rheingold, S., Albano, E., Kadota, R., Luchtman-Jones, L., Bomgaars, L., Gaynon, P., Goldman, S., Ritchey, K., Arceci, R., Altman, A., Stine, K., Steinherz, L. & Steinherz, P. (2009) Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia. Journal of Clinical Oncology, 27, 4392-4397.
16. Klingebiel, T., Cornish, J., Labopin, M., Locatelli, F., Darbyshire, P., Handgretinger, R., Balduzzi, A., Owoc-Lempach, J., Fagioli, F., Or, R., Peters, C., Aversa, F., Polge, E., Dini, G. & Rocha, V. (2010) Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group. Blood, 115, 3437-3446.
17. Lang, P., Greil, J., Bader, P., Handgretinger, R., Klingebiel, T., Schumm, M., Schlegel, P.G., Feuchtinger, T., Pfeiffer, M., Scheel-Walter, H., Fuhrer, M., Martin, D. & Niethammer, D. (2004) Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells, Molecules, & Diseases, 33, 281-287.
18. Lang, P., Mueller, I., Greil, J., Bader, P., Schumm, M., Pfeiffer, M., Hoelle, W., Klingebiel, T., Heinzelmann, F., Belka, C., Schlegel, P.G., Kremens, B., Woessmann, W. & Handgretinger, R. (2008) Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. Blood Cells Molecules and Diseases, 40, 33-39.
19. Lindemans, C.A., Chiesa, R., Amrolia, P.J., Rao, K., Nikolajeva, O., de Wildt, A., Gerhardt, C.E., Gilmour, K.C., Bierings, B., Veys, P. & Boelens, J.J. (2014) Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome. Blood, 123, 126-132.
20. Liu, D.H., Zhao, X.S., Chang, Y.J., Liu, Y.K., Xu, L.P., Chen, H., Han, W., Chen, Y.H., Wang, Y. & Huang, X.J. (2011) The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation. Pediatric Blood and Cancer, 57, 135-141.
21. Locatelli, F., Pende, D., Maccario, R., Mingari, M.C., Moretta, A. & Moretta, L. (2009) Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference. Clinical Immunology, 133, 171-178.
22. Marks, D.I., Khattry, N., Cummins, M., Goulden, N., Green, A., Harvey, J., Hunt, L.P., Keen, L., Robinson, S.P., Steward, C.G. & Cornish, J.M. (2006) Haploidentical stem cell transplantation for children with acute leukaemia. British Journal of Haematology, 134, 196-201.
23. Mulanovich, V.E., Jiang, Y., de Lima, M., Shpall, E.J., Champlin, R.E. & Ciurea, S.O. (2011) Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation. American Journal of Blood Research, 1, 98-105.
24. Munchel, A., Kesserwan, C., Symons, H.J., Luznik, L., Kasamon, Y.L., Jones, R.J. & Fuchs, E.J. (2011) Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide. Pediatric Reports, 3(Suppl. 2), e15.
25. Ortin, M., Raj, R., Kinning, E., Williams, M. & Darbyshire, P.J. (2002) Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin. Bone Marrow Transplantation, 30, 359-366.
26. Otto, M., Barfield, R.C., Iyengar, R., Gatewood, J., Muller, I., Holladay, M.S., Houston, J., Leung, W. & Handgretinger, R. (2005) Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation. Journal of Immunotherapy, 28, 73-78.
27. Perez-Martinez, A., Gonzalez-Vicent, M., Valentin, J., Aleo, E., Lassaletta, A., Sevilla, J., Vicario, J.L., Ramirez, M. & Diaz, M.A. (2012) Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia. Bone Marrow Transplantation, 47, 1419-1427.
28. Peters, C., Matthes-Martin, S., Fritsch, G., Holter, W., Lion, T., Witt, V., Hocker, P., Fischer, G., Dieckmann, K., Handgretinger, R., Klingebiel, T. & Gadner, H. (1999) Transplantation of highly purified peripheral blood CD34 + cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia, 13, 2070-2078.
29. Pfeiffer, M.M., Feuchtinger, T., Teltschik, H.M., Schumm, M., Muller, I., Handgretinger, R. & Lang, P. (2010) Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children. Haematologica, 95, 1381-1388.
30. Pfeiffer, M.M., Schumm, M., Muller, I., Handgretinger, R. & Lang, P. (2012) IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT. Leukemia, 26, 2435-2439.
31. Reisner, Y., Hagin, D. & Martelli, M.F. (2011) Haploidentical hematopoietic transplantation: current status and future perspectives. Blood, 118, 6006-6017.
32. Rocha, V., Kabbara, N., Ionescu, I., Ruggeri, A., Purtill, D. & Gluckman, E. (2009) Pediatric related and unrelated cord blood transplantation for malignant diseases. Bone Marrow Transplantation, 44, 653-659.
33. Ruggeri, L., Mancusi, A., Capanni, M., Urbani, E., Carotti, A., Aloisi, T., Stern, M., Pende, D., Perruccio, K., Burchielli, E., Topini, F., Bianchi, E., Aversa, F., Martelli, M.F. & Velardi, A. (2007) Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood, 110, 433-440.
34. Ruggeri, A., Michel, G., Dalle, J.H., Caniglia, M., Locatelli, F., Campos, A., de Heredia, C.D., Mohty, M., Hurtado, J.M., Bierings, M., Bittencourt, H., Mauad, M., Purtill, D., Cunha, R., Kabbara, N., Gluckman, E., Labopin, M., Peters, C. & Rocha, V. (2012) Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis. Leukemia, 26, 2455-2461.
35. Safdar, A., Rodriguez, G.H., De Lima, M.J., Petropoulos, D., Chemaly, R.F., Worth, L.L., Shpall, E.J., Rolston, K.V., Raad, I.I., Chan, K.W. & Champlin, R.E. (2007) Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine (Baltimore), 86, 324-333.
36. Schumm, M., Handgretinger, R., Pfeiffer, M., Feuchtinger, T., Kuci, S., Faul, C., Vogel, W., Bethge, W. & Lang, P. (2006) Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations. Cytotherapy, 8, 465-472.
37. Schumm, M., Feuchtinger, T., Pfeiffer, M., Hoelle, W., Bethge, W., Ebinger, M., Kuci, S., Handgretinger, R. & Lang, P. (2007) Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation. Bone Marrow Transplantation, 39, 767-773.
38. Schumm, M., Lang, P., Bethge, W., Faul, C., Feuchtinger, T., Pfeiffer, M., Vogel, W., Huppert, V. & Handgretinger, R. (2013) Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. Cytotherapy, 15, 1253-1258.